Development and Alpha Testing of Specifications for a Prolonged Opioid Prescribing Electronic Clinical Quality Measure (eCQM).
Avery Pullmana b, Ania Syrowatkaa b, Alexandra Busingera b, Michael Sainlairea b, Stuart R. Lipsitza b, Tien Thaia b, Woongki Kima b, David Westfall Batesa b, Patricia C. Dykesa b
- aBrigham and Women's Hospital, Boston, MA
- bHarvard Medical School, Boston, MA
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
Brigham and Women's Hospital (BWH) has received funding from the Centers for Medicare and Medicaid Services (CMS) to design and implement an electronic clinical quality measure (eCQM) assessing the rate of prolonged opioid prescribing practices following Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA). Utilizing an existing guideline, 'prolonged prescribing' has been defined as opioid prescriptions that exceed 42 days (6 weeks) following surgery. This measure was tested on 12,803 Partners' Healthcare (PHS) patients. Findings demonstrated that after 42 days, meeting the criteria for 'prolonged prescribing' as defined by the proposed measure, 3.7% of THA patients and 12.1% of TKA patients were still receiving opioids. With a better understanding of how specific clinician group post-operative prescribing practices compare with their peers and incorporating monetary incentives through the MIPS participation pathway of the Quality Payment Program (QPP), this measure will motivate orthopedic practices to improve their prescribing patterns, ultimately driving evidence-based quality improvement.
TL;DRA better understanding of how specific clinician group post-operative prescribing practices compare with their peers will motivate orthopedic practices to improve their prescribing patterns, ultimately driving evidence-based quality improvement. (Semantic Scholar)